The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 190.00
Bid: 185.00
Ask: 195.00
Change: 5.00 (2.70%)
Spread: 10.00 (5.405%)
Open: 185.00
High: 192.50
Low: 185.00
Prev. Close: 185.00
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Strategic Alliance

8 Dec 2005 08:23

Synexus Clinical Research PLC08 December 2005 Synexus Clinical Research plc ("Synexus") Forms Strategic Alliance with ICRI Research (P) Ltd. ("IRL") to establish India's first patient-recruitment Site Management Organisation (SMO) Synexus Clinical Research plc, the provider of clinical trials services to theglobal pharmaceutical industry, has entered into a strategic alliance with theIndian Clinical Research Institute, through the latter's Mumbai-based subsidiaryIRL. IRL-Synexus will establish a chain of fully owned GCP-compliant investigatorsites (IRL-Synexus Clinical Research Centres) across India, and the first hasnow been formally opened in Mumbai. All patients will be recruited throughinternationally accepted methods and the first patient is expected to berecruited to a trial in the first three months of 2006. Under the terms of the agreement, IRL's full-time GCP trained clinical researchteam are further trained by Synexus in UK, to ensure full implementation inIndia of Synexus' operating procedures. Synexus will continue to support andmonitor the centres in India to ensure compliance with these procedures. Synexus recently listed on AIM, with the declared strategy of replicating,through acquisitions and partnerships, its successful UK operations across arange of countries important to its clients for running clinical trials. TheIRL-Synexus alliance is the first of these strategic steps. Commenting on the collaboration, Dr Ian Smith, Medical Director of Synexus,said: "India possesses tremendous potential to become a preferred location forresearch and development for the global biotechnology and pharmaceutical sector.I am delighted that Synexus has formed an alliance with IRL, whose core valuesof expertise, proficiency and training blend perfectly with our systematic andeffective approach." Press enquiries Synexus Clinical Research plc Tel: +44 (0)1257 230 723Michael Redmond, Executive ChairmanDr Ian Smith, Medical Director Biddicks Tel: +44 (0)20 7448 1000Zoe Biddick NOTES TO EDITORS Synexus Clinical Research plc was formed in 1998 and is the largest patientrecruitment organisation in Europe. Synexus undertakes clinical trials servicesfor the global pharmaceutical industry, managing patients on clinical trials onbehalf of pharmaceutical companies and contract research organisations. Synexussources patient, assesses them for suitability through a screening process,manages the patients on the trials and collates data before reporting back toits client. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Nov 20187:00 amRNSTrading Update
27th Nov 201811:29 amRNSDirector/PDMR Shareholding
29th Oct 201810:04 amRNSDirector/PDMR Shareholding
5th Oct 20187:00 amRNSDirector/PDMR Shareholding
25th Sep 20187:00 amRNSDirectorate Change
28th Aug 20187:00 amRNSSynectics secures UK custodial sites
14th Aug 20184:00 pmRNSDirector/PDMR Shareholding
17th Jul 20187:00 amRNSInterim Results
27th Jun 20187:00 amRNSNotification of Interim Results
1st Jun 20187:00 amRNSDirectorate Change
30th May 20183:23 pmRNSHolding(s) in Company
23rd May 20187:00 amRNSContract Win
11th May 20183:38 pmRNSDirector/PDMR Shareholding
27th Apr 201811:42 amRNSDirector/PDMR Shareholding
26th Apr 20181:12 pmRNSResult of AGM
26th Apr 20187:00 amRNSAGM Statement
29th Mar 20182:09 pmRNSDirector/PDMR Shareholding
27th Mar 20184:52 pmRNSHolding(s) in Company
26th Mar 20187:00 amRNSContract Win
21st Mar 20187:01 amRNSAnnual Report and Notice of AGM
21st Mar 20187:00 amRNSDirectorate Change
20th Feb 20187:00 amRNSFinal Results
23rd Jan 20187:00 amRNSNotification of Final Results
8th Jan 20183:19 pmRNSElectronic Communication with Shareholders
4th Jan 20181:15 pmRNSHolding(s) in Company
13th Dec 20171:43 pmRNSHolding(s) in Company
12th Dec 20177:00 amRNSTrading Update
1st Dec 20175:35 pmRNSAIM Disclosure Update
30th Oct 20174:40 pmRNSDirector/PDMR Shareholding
16th Oct 20173:23 pmRNSDirector/PDMR Shareholding
22nd Sep 20173:02 pmRNSDirector/PDMR Shareholding
21st Sep 20173:58 pmRNSHolding(s) in Company
6th Sep 201710:01 amRNSDirector/PDMR Shareholding
29th Aug 20175:11 pmRNSHolding(s) in Company
18th Jul 20177:00 amRNSInterim Results
6th Jul 20177:00 amRNSNotification of Interim Results
6th Jun 20175:54 pmRNSRe-appointment of Auditor
26th May 201710:04 amRNSDirector/PDMR Shareholding
28th Apr 20174:01 pmRNSDirector/PDMR Shareholding
27th Apr 20171:08 pmRNSResult of AGM
27th Apr 20177:00 amRNSAGM Statement
11th Apr 20177:00 amRNSContract Wins
24th Mar 20172:43 pmRNSPosting of Annual Report and AGM Notice
7th Mar 20179:55 amRNSDirector/PDMR Shareholding
2nd Mar 201711:32 amRNSDirector/PDMR Shareholding
21st Feb 20177:00 amRNSFinal Results
30th Jan 20177:00 amRNSNotification of Final Results
10th Jan 20177:00 amRNSAdoption of Financial Reporting Standard 101
8th Dec 20167:00 amRNSYear End Trading Update
21st Oct 20162:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.